GREGORY FORRESTER: Open Payments
NPI 1184284473 · GRAVETTE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,789 in 89 payments from 11 companies in 2025. Trend: 2023 $1,640 · 2024 $1,927 · 2025 $1,789
Food & beverage: $1,680Education: $109
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $396 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 38 | $390 |
| Vanda Pharmaceuticals Inc. | 12 | $271 |
| Janssen Pharmaceuticals, Inc | 5 | $198 |
| Teva Pharmaceuticals USA, Inc. | 5 | $173 |
| Astellas Pharma US Inc | 1 | $121 |
| E.R. Squibb & Sons, L.L.C. | 5 | $104 |
| IDORSIA PHARMACEUTICALS US INC | 2 | $52 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $49 |
| Lundbeck LLC | 1 | $17 |
Products named: VRAYLAR, CAPLYTA, FANAPT, SPRAVATO, Veozah, COBENFY, AUSTEDO XR, Quviviq.
Industry payments across AR — which companies pay providers there.
